{"date":"2026-03-19","count":39,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7754-2026-03-19-1828-4xw05f","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"18:28:58","subject":"本公司董事會決議虧損撥補案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-03-19 18:28，「本公司董事會決議虧損撥補案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2026-03-19-1828-1f8il51","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"18:28:34","subject":"公告本公司董事會追認修訂114年員工認股權憑證發行及認股辦法","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-03-19 18:28，「公告本公司董事會追認修訂114年員工認股權憑證發行及認股辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2026-03-19-1827-drgvb6","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"18:27:57","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-03-19 18:27，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2026-03-19-1825-1howjn","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"18:25:26","subject":"公告本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-03-19 18:25，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2026-03-19-1823-7j886t","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"18:23:27","subject":"公告本公司董事會通過民國114年度個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-03-19 18:23，「公告本公司董事會通過民國114年度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2026-03-19-1800-bwopfv","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"18:00:26","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2026-03-19 18:00，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2026-03-19-1759-zm3ruq","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"17:59:43","subject":"公告本公司董事會通過召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2026-03-19 17:59，「公告本公司董事會通過召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7773-2026-03-19-1758-bwopfv","company_id":"7773","company":"富禾生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"17:58:45","subject":"公告本公司董事會決議不分派股利","clause":"第31款","fact_date":"2026-03-19","cite_as":"公開資訊觀測站重大訊息：富禾生醫（7773），2026-03-19 17:58，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2026-03-19-1754-11wjw0o","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"17:54:26","subject":"公告本公司董事會決議股利分派","clause":"第31款","fact_date":"2026-03-19","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2026-03-19 17:54，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2026-03-19-1753-1c0djxj","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"17:53:44","subject":"公告本公司設置公司治理主管","clause":"第11款","fact_date":"2026-03-19","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2026-03-19 17:53，「公告本公司設置公司治理主管」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2026-03-19-1753-b90cvr","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"17:53:23","subject":"公告本公司技術長任命案","clause":"第11款","fact_date":"2026-03-19","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2026-03-19 17:53，「公告本公司技術長任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2026-03-19-1752-1kudrj8","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"17:52:58","subject":"公告本公司董事會決議通過114年度員工(含基層員工)酬勞及董事酬勞分派案","clause":"第44款","fact_date":"2026-03-19","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2026-03-19 17:52，「公告本公司董事會決議通過114年度員工(含基層員工)酬勞及董事酬勞分派案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2026-03-19-1751-1b89la1","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"17:51:41","subject":"公告本公司董事會通過114年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2026-03-19 17:51，「公告本公司董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-03-19-1748-3rtkow","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-03-19","time":"17:48:11","subject":"本公司受邀參加法人說明會資訊","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-03-19 17:48，「本公司受邀參加法人說明會資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7773-2026-03-19-1747-11b1948","company_id":"7773","company":"富禾生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"17:47:40","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第32款","fact_date":"2026-03-19","cite_as":"公開資訊觀測站重大訊息：富禾生醫（7773），2026-03-19 17:47，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2026-03-19-1746-11b1948","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"17:46:03","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2026-03-19 17:46，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7773-2026-03-19-1739-7j886t","company_id":"7773","company":"富禾生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"17:39:04","subject":"公告本公司董事會通過民國114年度個別財務報告","clause":"第43款","fact_date":"2026-03-19","cite_as":"公開資訊觀測站重大訊息：富禾生醫（7773），2026-03-19 17:39，「公告本公司董事會通過民國114年度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2026-03-19-1738-difvce","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"17:38:17","subject":"公告本公司代理發言人任命案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2026-03-19 17:38，「公告本公司代理發言人任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2026-03-19-1737-hlxb99","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"17:37:16","subject":"公告本公司內部稽核主管任命案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2026-03-19 17:37，「公告本公司內部稽核主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2026-03-19-1736-19179h6","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"17:36:09","subject":"公告本公司董事會通過114年合併財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2026-03-19 17:36，「公告本公司董事會通過114年合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7790-2026-03-19-1735-92x690","company_id":"7790","company":"思必瑞特","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"17:35:44","subject":"董事會決議股利分派","clause":"第31款","fact_date":"2026-03-19","cite_as":"公開資訊觀測站重大訊息：思必瑞特（7790），2026-03-19 17:35，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7790-2026-03-19-1735-xfv07u","company_id":"7790","company":"思必瑞特","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"17:35:28","subject":"公告董事會決議召開115年股東常會相關事宜","clause":"第32款","fact_date":"2026-03-19","cite_as":"公開資訊觀測站重大訊息：思必瑞特（7790），2026-03-19 17:35，「公告董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4170-2026-03-19-1715-11b1948","company_id":"4170","company":"鑫品生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"17:15:08","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第32款","fact_date":"2026-03-19","cite_as":"公開資訊觀測站重大訊息：鑫品生醫（4170），2026-03-19 17:15，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7790-2026-03-19-1656-jrdie1","company_id":"7790","company":"思必瑞特","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"16:56:59","subject":"公告本公司董事會決議發行115年度第一次員工認股權憑證及認股辦法","clause":"第9款","fact_date":"2026-03-19","cite_as":"公開資訊觀測站重大訊息：思必瑞特（7790），2026-03-19 16:56，「公告本公司董事會決議發行115年度第一次員工認股權憑證及認股辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7790-2026-03-19-1647-nlyvt7","company_id":"7790","company":"思必瑞特","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"16:47:51","subject":"公告本公司董事會決議盈餘暨資本公積發行新股案","clause":"第9款","fact_date":"2026-03-19","cite_as":"公開資訊觀測站重大訊息：思必瑞特（7790），2026-03-19 16:47，「公告本公司董事會決議盈餘暨資本公積發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-03-19-1644-1howjn","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"16:44:48","subject":"公告本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-03-19 16:44，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7790-2026-03-19-1642-5j9yh6","company_id":"7790","company":"思必瑞特","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"16:42:39","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第43款","fact_date":"2026-03-19","cite_as":"公開資訊觀測站重大訊息：思必瑞特（7790），2026-03-19 16:42，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-03-19-1641-jduxxi","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"16:41:41","subject":"代子公司公告改派朗齊株式會社總經理","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-03-19 16:41，「代子公司公告改派朗齊株式會社總經理」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-03-19-1640-1w38uny","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"16:40:20","subject":"代子公司公告改派朗齊株式會社董事","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-03-19 16:40，「代子公司公告改派朗齊株式會社董事」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-03-19-1638-5j9yh6","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"16:38:53","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-03-19 16:38，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-03-19-1637-2iz4hx","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"16:37:31","subject":"公告本公司董事會決議不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-03-19 16:37，「公告本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-03-19-1623-10yb8rh","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-03-19","time":"16:23:18","subject":"本公司受邀參加元富證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-03-19 16:23，「本公司受邀參加元富證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6580-2026-03-19-1616-11rd7ei","company_id":"6580","company":"台睿","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"16:16:48","subject":"公告本公司董事會決議召開民國115年股東常會相關事宜。","clause":"第32款","fact_date":"2026-03-19","cite_as":"公開資訊觀測站重大訊息：台睿（6580），2026-03-19 16:16，「公告本公司董事會決議召開民國115年股東常會相關事宜。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6580-2026-03-19-1522-bwopfv","company_id":"6580","company":"台睿","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"15:22:48","subject":"公告本公司董事會決議不分派股利","clause":"第31款","fact_date":"2026-03-19","cite_as":"公開資訊觀測站重大訊息：台睿（6580），2026-03-19 15:22，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6580-2026-03-19-1515-d7ntug","company_id":"6580","company":"台睿","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"15:15:50","subject":"公告本公司董事會通過114年度合併財務報告。","clause":"第43款","fact_date":"2026-03-19","cite_as":"公開資訊觀測站重大訊息：台睿（6580），2026-03-19 15:15，「公告本公司董事會通過114年度合併財務報告。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6580-2026-03-19-1514-1stomkw","company_id":"6580","company":"台睿","market":"興櫃","industry":"生技醫療","date":"2026-03-19","time":"15:14:10","subject":"公告本公司董事會通過114年度個體財務報告。","clause":"第43款","fact_date":"2026-03-19","cite_as":"公開資訊觀測站重大訊息：台睿（6580），2026-03-19 15:14，「公告本公司董事會通過114年度個體財務報告。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-03-19-1408-go0lxv","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-03-19","time":"14:08:23","subject":"代子公司CARLSBAD TECHNOLOGY,INC.公告董事會決議召開2026年股東會","clause":"第17款","fact_date":"2026-03-19","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-03-19 14:08，「代子公司CARLSBAD TECHNOLOGY,INC.公告董事會決議召開2026年股東會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-03-19-1404-7jw05f","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-03-19","time":"14:04:39","subject":"代子公司CARLSBAD TECHNOLOGY,INC.公告董事會決議發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-03-19 14:04，「代子公司CARLSBAD TECHNOLOGY,INC.公告董事會決議發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-03-19-1054-1fqkmsr","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-03-19","time":"10:54:50","subject":"澄清媒體報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-03-19 10:54，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}